Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1123 | 995 | 1279 | 932 | 1326 | 2467 |
Fund Return | 12.27% | -0.48% | 27.88% | -2.33% | 5.8% | 9.45% |
Place in category | 1914 | 1727 | 883 | 1415 | 1052 | 112 |
% in Category | 67 | 61 | 31 | 59 | 59 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LGeneration Global CHF M A | 1.78B | 14.63 | -1.36 | 9.89 | ||
LGeneration Global CHF M D | 1.78B | 14.63 | -1.36 | 9.89 | ||
LGeneration Global CHF I | 1.78B | 12.84 | -1.74 | 9.88 | ||
LGeneration Global CHF P A | 1.78B | 12.27 | -2.33 | 9.43 | ||
LGeneration Global CHF S A | 1.78B | 13.93 | -0.60 | 12.40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Fundc | 15.52B | 14.59 | 1.68 | 10.79 | ||
Capital Group New Perspective Funzc | 15.52B | 14.32 | 1.42 | 10.59 | ||
Capital Group New Perspective Fuzdc | 15.52B | 14.33 | 1.41 | 10.58 | ||
Capital Group New Perspective Fubc | 15.52B | 13.60 | 0.67 | 9.71 | ||
LGeneration Global CHF M A | 1.78B | 14.63 | -1.36 | 9.89 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 8.02 | 417.00 | +1.00% | |
Amazon.com | US0231351067 | 7.80 | 197.12 | -0.64% | |
Becton Dickinson | US0758871091 | 5.48 | 224.00 | -0.64% | |
CBRE A | US12504L1098 | 3.70 | 135.43 | +2.87% | |
Thermo Fisher Scientific | US8835561023 | 3.60 | 513.26 | -0.55% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review